Cas:239079-89-1 1-Bromo-2-methyl-3-nitro-5-(trifluoromethyl)benzene manufacturer & supplier

We serve Chemical Name:1-Bromo-2-methyl-3-nitro-5-(trifluoromethyl)benzene CAS:239079-89-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-Bromo-2-methyl-3-nitro-5-(trifluoromethyl)benzene

Chemical Name:1-Bromo-2-methyl-3-nitro-5-(trifluoromethyl)benzene
CAS.NO:239079-89-1
Synonyms:Benzene,1-bromo-2-methyl-3-nitro-5-(trifluoromethyl);2-Bromo-6-nitro-4-trifluoromethyltoluene
Molecular Formula:C8H5BrF3NO2
Molecular Weight:284.03000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:45.82000
Exact Mass:282.94600
LogP:4.20770

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzene,1-bromo-2-methyl-3-nitro-5-(trifluoromethyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-6-nitro-4-trifluoromethyltoluene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzene,1-bromo-2-methyl-3-nitro-5-(trifluoromethyl) Use and application,Benzene,1-bromo-2-methyl-3-nitro-5-(trifluoromethyl) technical grade,usp/ep/jp grade.


Related News: The mode of cooperation between domestic API companies and large international companies can lower the export threshold. 1-Bromo-2-methyl-3-nitro-5-(trifluoromethyl)benzene manufacturer The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application. 1-Bromo-2-methyl-3-nitro-5-(trifluoromethyl)benzene supplier A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. 1-Bromo-2-methyl-3-nitro-5-(trifluoromethyl)benzene vendor A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. 1-Bromo-2-methyl-3-nitro-5-(trifluoromethyl)benzene factory In addition, due to environmental constraints, Yancheng Lianhua’s first pesticide project ANBE was put into operation at a slower pace than expected, and other pesticide projects were also put into operation.